| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.6M | — | +3.0% |
| Cost of Revenue | $2.2M | — | +11.7% |
| Gross Profit | $7.4M | — | +0.6% |
| R&D Expense | $660K | — | +217.3% |
| SG&A Expense | $5.3M | — | +17.5% |
| Operating Income | -$1.1M | — | -214.0% |
| Interest Expense | $546K | — | -71.4% |
| Net Income | -$1.4M | — | +74.6% |
| EPS (Basic) | -$0.17 | — | +74.2% |
| EPS (Diluted) | -$0.17 | — | +74.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.8M | -9.9% | +26.8% |
| Accounts Receivable | $6.0M | +10.7% | +55.2% |
| Inventory | $5.9M | -0.5% | +8.2% |
| Current Assets | $24.0M | -2.7% | +27.2% |
| Total Assets | $37.1M | -0.7% | +20.2% |
| Current Liabilities | $18.3M | +2.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $397K | — | +126.2% |
| Capital Expenditures | $23K | — | -85.8% |
| Investing Cash Flow | -$158K | — | +2.5% |
| Financing Cash Flow | -$1.4M | — | -2389.5% |
| Free Cash Flow | $374K | — | +122.3% |
| -61.3% |
| Long-term Debt | $20.5M | -6.3% | — |
| Total Liabilities | $35.3M | -1.3% | -26.8% |
| Stockholders' Equity | $1.8M | +13.5% | +110.6% |